Provexis Share News (PXS)

Provexis Annual Loss Widens, Starts New Year On Positive Note

LONDON (Alliance News) - Provexis PLC reported Thursday that a big rise in share-based payments led to a slightly widened loss for the 2018 financial year.However, Provexis said it has made

Provexis Appoints Frederic Boned As Non-Executive Director

LONDON (Alliance News) - Provexis PLC said Wednesday it appointed Frederic Boned as non-executive director with immediate effect.Currently, Boned is EMEA vice president of DSM's Human a

Provexis Narrows Loss But Will Need To Raise Funds In Next 4 Months (ALLISS)

Provexis boosts revenue and narrows loss

(ShareCast News) - Developer of the proprietary Fruitflow heart-health functional food ingredient Provexis posted its unaudited interim results for the six months to 30 September on Friday, with total revenue for the period of £0.12m. The AIM-traded company said that was a threefold increase from th

Provexis reports positive results from Fruitflow tests

(ShareCast News) - Developer of the Fruitflow heart-health functional food ingredient Provexis updated the market on its collaboration agreement with the University of Oslo on Tuesday, undertaking further research into the relationship between Fruitflow and blood pressure regulation. The AIM-traded

Provexis says partnership will widen use of Fruitflow

(ShareCast News) - Developer of the Fruitflow heart-health functional food product, Provexis, announced on Friday that the company's alliance partner for Fruitflow, DSM Nutritional Products, has entered into a strategic collaboration agreement for Fruitflow with BY-HEALTH Co, a substantial listed Ch

UK Shareholder Meetings Calendar - Next 7 Days

Provexis chairman joins possible fundraising

(ShareCast News) - Provexis, the developer and licenser of the proprietary Fruitflow heart health food ingredient, updated the market on its ongoing seeking of funding on Wednesday, with an uplift in interest thanks to its chairman. The AIM-traded firm had announced on 9 June that it was in late sta

WINNERS & LOSERS SUMMARY: Investors Hammer Brammer For Profit Warning

Provexis Launches New Product, Continues Fundraising Talks (ALLISS)

Provexis In Late Stage Talks With Investors For Fundraising (ALLISS)

Provexis Expects To Report "Another Strong Year Of Progress"

DIRECTOR DEALINGS SUMMARY: Provexis Directors Buy 4.9 Million Shares

DIRECTOR DEALINGS: Provexis Directors Buy 4.9 Million Shares

Provexis Remains Positive On Outlook As Pretax Loss Widens Slightly